These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 4224206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
    Karaivanova MK.
    Eksp Med Morfol; 1974; 13(4):237-42. PubMed ID: 4219353
    [No Abstract] [Full Text] [Related]

  • 4. The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice.
    Sheard CE, Double JA, Berenbaum MC.
    Br J Cancer; 1971 Dec; 25(4):838-44. PubMed ID: 5144544
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
    Parkanskiĭ MN, Konovalova NP, Emanuél' N.
    Izv Akad Nauk SSSR Biol; 1973 Dec; (1):144-6. PubMed ID: 4218850
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
    Keller HJ, Keppler B, Schmähl D.
    Arzneimittelforschung; 1982 Dec; 32(8):806-7. PubMed ID: 6890355
    [Abstract] [Full Text] [Related]

  • 9. [The effect of various antitumor drugs on developing Schwez erythromyelosis in rats].
    Emanuel' NM, Dronova LM, Erokhin VN, Belich EI.
    Izv Akad Nauk SSSR Biol; 1970 Dec; 1():87-92. PubMed ID: 5275614
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K, Witting U, Rauen HM.
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract] [Full Text] [Related]

  • 13. [Time factor in evaluating antineoplastic agents].
    Syrkin AB.
    Farmakol Toksikol; 1972 Jan; 35(1):75-9. PubMed ID: 5011523
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)].
    Matthias M, Tanneberger S, Gummel H.
    Arch Geschwulstforsch; 1970 Jan; 36(3):240-6. PubMed ID: 5498278
    [No Abstract] [Full Text] [Related]

  • 17. Cytotoxic activity of mechlorethamine and melphalan against cultured tumor cells: potentiation by caffeine.
    Merriman RL, Sladek NE.
    J Pharmacol Exp Ther; 1978 Aug; 206(2):388-97. PubMed ID: 682121
    [No Abstract] [Full Text] [Related]

  • 18. Ultrastructural changes induced in Walker carcinosarcoma by treatment with dihematoporphyrin ester and light in animals with diabetes mellitus.
    Dima VF, Ionescu MD.
    Roum Arch Microbiol Immunol; 2000 Aug; 59(1-2):119-30. PubMed ID: 11845470
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of chronic leukemias with benzene and its homologues; role of choline and methionine].
    BRAIER L.
    Sang; 1953 Aug; 24(7):603-12. PubMed ID: 13135378
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.